Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Allied Market Research | PRODUCT CODE: 1566977

Cover Image

PUBLISHER: Allied Market Research | PRODUCT CODE: 1566977

Vacuum-assisted Biopsy Devices Market By Product , By Type By Technique By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

PUBLISHED:
PAGES: 280 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Business License)
USD 4425
PDF (Enterprise User License) & Excel (Data Pack) & Free Update
USD 7412

Add to Cart

Vacuum-assisted Biopsy Devices Market

The vacuum-assisted biopsy devices market was valued at $0.9 billion in 2023 and is projected to reach $2.7 billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033.

Vacuum-assisted biopsy devices are the medical tools used to procure tissue samples from a body organ for diagnostic purposes. The usage of vacuum-assisted devices over traditional biopsy methods enables the extraction of large and more contiguous tissue samples, thereby elevating the precision of histopathological analysis. Moreover, extraction through these devices remains minimally invasive as it involves a single incision performed under local anesthesia, hence reducing the discomfort of patients and speeding their recovery time.

Increase in the incidence of cancer, constant improvements in cancer diagnostics, and surge in preference for minimally invasive procedures are the key drivers of the vacuum-assisted biopsy devices market. Furthermore, rise in awareness among individuals pertaining to cancer has boosted the prevalence of screening tests and early diagnosis, thereby boosting the demand for vacuum-assisted biopsy devices. Currently, the use of vacuum-assisted biopsy device for the removal of benign breast tumor is an emerging trend. The device is proving to be advantageous in eradicating surgeries and enhancing precision in the examination process.

However, the cost of procuring the device is significantly high, particularly for small-scale medical facilities and hospitals in rural regions, hence restraining the growth of the market. Moreover, lack of flexibility in such devices leads to positioning limitations which limit their applicability. On the contrary, innovations in the design and features of vacuum-assisted biopsy devices present lucrative opportunities for market expansion. For instance, the integration of the device with advanced imaging techniques such as ultrasound and MRI is enhancing its applicability and accuracy through real-time supervision.

Segment Review

The vacuum-assisted biopsy devices market is segmented into product, type, technique, applications, end user, and region. By product, the market is bifurcated into vacuum-assisted biopsy systems and vacuum-assisted biopsy needles. As per type, it is divided into 9-12G, <9G, and >12G. Depending on technique, it is classified into ultrasound-guided biopsy, stereotactic, guided biopsy, MRI-guided biopsy, and others. According to application, it is categorized into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. On the basis of end users, it is segmented into hospitals, academic & research institutes, diagnostic & imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the vacuum-assisted biopsy needles segment dominated the market in 2023.

As per type, the 9-12G segment was the highest shareholder in 2023.

Depending on technique, the ultrasound-guided biopsy segment accounted for a high market share in 2023.

According to application, the breast biopsy segment was the highest shareholder in 2023.

On the basis of end user, the hospitals segment held a large market share in 2023.

Region wise, North America exhibits robust market growth.

Competition Analysis

The major players operating in the global vacuum-assisted biopsy devices market include Becton, Dickinson and Company, Cook Medical, Devicor Medical Products, Inc., Argon Medical., B. Braun Melsungen AG, Cardinal Health, Olympus Corporation, Boston Scientific Corporation, Medtronic Plc, and Inrad Inc. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Vacuum-assisted biopsy systems
  • Vacuum-assisted biopsy needles

By Type

  • 9-12G
  • Less than 9G
  • and12G

By Technique

  • Ultrasound-guided biopsy
  • Stereotactic
  • Guided biopsy
  • MRI-guided biopsy
  • Others

By Application

  • Breast Biopsy
  • Lung Biopsy
  • Colorectal Biopsy
  • Colorectal Biopsy
  • Others

By End User

  • Hospitals
  • Academic and Research Institutes
  • Diagnostic and Imaging Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Becton, Dickinson and Company
    • Cook Group
    • Devicor Medical Products Inc
    • Argon Medical Devices, Inc.
    • B. Braun Melsungen AG
    • Cardinal Health
    • Olympus Corporation
    • Boston Scientific Corporation
    • Medtronic plc
    • Inrad Inc
Product Code: A324535

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Vacuum-assisted Biopsy Systems
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Vacuum-assisted Biopsy Needles
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Type
  • 5.2. 9-12G
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Less Than 9G
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. And12G
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TECHNIQUE

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Technique
  • 6.2. Ultrasound-guided Biopsy
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Stereotactic
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Guided Biopsy
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. MRI-guided Biopsy
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Others
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY APPLICATION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Application
  • 7.2. Breast Biopsy
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Lung Biopsy
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Colorectal Biopsy
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Colorectal Biopsy
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country
  • 7.6. Others
    • 7.6.1. Key Market Trends, Growth Factors and Opportunities
    • 7.6.2. Market Size and Forecast, By Region
    • 7.6.3. Market Share Analysis, By Country

CHAPTER 8: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY END USER

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By End User
  • 8.2. Hospitals
    • 8.2.1. Key Market Trends, Growth Factors and Opportunities
    • 8.2.2. Market Size and Forecast, By Region
    • 8.2.3. Market Share Analysis, By Country
  • 8.3. Academic And Research Institutes
    • 8.3.1. Key Market Trends, Growth Factors and Opportunities
    • 8.3.2. Market Size and Forecast, By Region
    • 8.3.3. Market Share Analysis, By Country
  • 8.4. Diagnostic And Imaging Centers
    • 8.4.1. Key Market Trends, Growth Factors and Opportunities
    • 8.4.2. Market Size and Forecast, By Region
    • 8.4.3. Market Share Analysis, By Country
  • 8.5. Others
    • 8.5.1. Key Market Trends, Growth Factors and Opportunities
    • 8.5.2. Market Size and Forecast, By Region
    • 8.5.3. Market Share Analysis, By Country

CHAPTER 9: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY REGION

  • 9.1. Market Overview
    • 9.1.1 Market Size and Forecast, By Region
  • 9.2. North America
    • 9.2.1. Key Market Trends and Opportunities
    • 9.2.2. Market Size and Forecast, By Product
    • 9.2.3. Market Size and Forecast, By Type
    • 9.2.4. Market Size and Forecast, By Technique
    • 9.2.5. Market Size and Forecast, By Application
    • 9.2.6. Market Size and Forecast, By End User
    • 9.2.7. Market Size and Forecast, By Country
    • 9.2.8. U.S. Vacuum-assisted Biopsy Devices Market
      • 9.2.8.1. Market Size and Forecast, By Product
      • 9.2.8.2. Market Size and Forecast, By Type
      • 9.2.8.3. Market Size and Forecast, By Technique
      • 9.2.8.4. Market Size and Forecast, By Application
      • 9.2.8.5. Market Size and Forecast, By End User
    • 9.2.9. Canada Vacuum-assisted Biopsy Devices Market
      • 9.2.9.1. Market Size and Forecast, By Product
      • 9.2.9.2. Market Size and Forecast, By Type
      • 9.2.9.3. Market Size and Forecast, By Technique
      • 9.2.9.4. Market Size and Forecast, By Application
      • 9.2.9.5. Market Size and Forecast, By End User
    • 9.2.10. Mexico Vacuum-assisted Biopsy Devices Market
      • 9.2.10.1. Market Size and Forecast, By Product
      • 9.2.10.2. Market Size and Forecast, By Type
      • 9.2.10.3. Market Size and Forecast, By Technique
      • 9.2.10.4. Market Size and Forecast, By Application
      • 9.2.10.5. Market Size and Forecast, By End User
  • 9.3. Europe
    • 9.3.1. Key Market Trends and Opportunities
    • 9.3.2. Market Size and Forecast, By Product
    • 9.3.3. Market Size and Forecast, By Type
    • 9.3.4. Market Size and Forecast, By Technique
    • 9.3.5. Market Size and Forecast, By Application
    • 9.3.6. Market Size and Forecast, By End User
    • 9.3.7. Market Size and Forecast, By Country
    • 9.3.8. Germany Vacuum-assisted Biopsy Devices Market
      • 9.3.8.1. Market Size and Forecast, By Product
      • 9.3.8.2. Market Size and Forecast, By Type
      • 9.3.8.3. Market Size and Forecast, By Technique
      • 9.3.8.4. Market Size and Forecast, By Application
      • 9.3.8.5. Market Size and Forecast, By End User
    • 9.3.9. France Vacuum-assisted Biopsy Devices Market
      • 9.3.9.1. Market Size and Forecast, By Product
      • 9.3.9.2. Market Size and Forecast, By Type
      • 9.3.9.3. Market Size and Forecast, By Technique
      • 9.3.9.4. Market Size and Forecast, By Application
      • 9.3.9.5. Market Size and Forecast, By End User
    • 9.3.10. UK Vacuum-assisted Biopsy Devices Market
      • 9.3.10.1. Market Size and Forecast, By Product
      • 9.3.10.2. Market Size and Forecast, By Type
      • 9.3.10.3. Market Size and Forecast, By Technique
      • 9.3.10.4. Market Size and Forecast, By Application
      • 9.3.10.5. Market Size and Forecast, By End User
    • 9.3.11. Italy Vacuum-assisted Biopsy Devices Market
      • 9.3.11.1. Market Size and Forecast, By Product
      • 9.3.11.2. Market Size and Forecast, By Type
      • 9.3.11.3. Market Size and Forecast, By Technique
      • 9.3.11.4. Market Size and Forecast, By Application
      • 9.3.11.5. Market Size and Forecast, By End User
    • 9.3.12. Spain Vacuum-assisted Biopsy Devices Market
      • 9.3.12.1. Market Size and Forecast, By Product
      • 9.3.12.2. Market Size and Forecast, By Type
      • 9.3.12.3. Market Size and Forecast, By Technique
      • 9.3.12.4. Market Size and Forecast, By Application
      • 9.3.12.5. Market Size and Forecast, By End User
    • 9.3.13. Rest of Europe Vacuum-assisted Biopsy Devices Market
      • 9.3.13.1. Market Size and Forecast, By Product
      • 9.3.13.2. Market Size and Forecast, By Type
      • 9.3.13.3. Market Size and Forecast, By Technique
      • 9.3.13.4. Market Size and Forecast, By Application
      • 9.3.13.5. Market Size and Forecast, By End User
  • 9.4. Asia-Pacific
    • 9.4.1. Key Market Trends and Opportunities
    • 9.4.2. Market Size and Forecast, By Product
    • 9.4.3. Market Size and Forecast, By Type
    • 9.4.4. Market Size and Forecast, By Technique
    • 9.4.5. Market Size and Forecast, By Application
    • 9.4.6. Market Size and Forecast, By End User
    • 9.4.7. Market Size and Forecast, By Country
    • 9.4.8. Japan Vacuum-assisted Biopsy Devices Market
      • 9.4.8.1. Market Size and Forecast, By Product
      • 9.4.8.2. Market Size and Forecast, By Type
      • 9.4.8.3. Market Size and Forecast, By Technique
      • 9.4.8.4. Market Size and Forecast, By Application
      • 9.4.8.5. Market Size and Forecast, By End User
    • 9.4.9. China Vacuum-assisted Biopsy Devices Market
      • 9.4.9.1. Market Size and Forecast, By Product
      • 9.4.9.2. Market Size and Forecast, By Type
      • 9.4.9.3. Market Size and Forecast, By Technique
      • 9.4.9.4. Market Size and Forecast, By Application
      • 9.4.9.5. Market Size and Forecast, By End User
    • 9.4.10. Australia Vacuum-assisted Biopsy Devices Market
      • 9.4.10.1. Market Size and Forecast, By Product
      • 9.4.10.2. Market Size and Forecast, By Type
      • 9.4.10.3. Market Size and Forecast, By Technique
      • 9.4.10.4. Market Size and Forecast, By Application
      • 9.4.10.5. Market Size and Forecast, By End User
    • 9.4.11. India Vacuum-assisted Biopsy Devices Market
      • 9.4.11.1. Market Size and Forecast, By Product
      • 9.4.11.2. Market Size and Forecast, By Type
      • 9.4.11.3. Market Size and Forecast, By Technique
      • 9.4.11.4. Market Size and Forecast, By Application
      • 9.4.11.5. Market Size and Forecast, By End User
    • 9.4.12. South Korea Vacuum-assisted Biopsy Devices Market
      • 9.4.12.1. Market Size and Forecast, By Product
      • 9.4.12.2. Market Size and Forecast, By Type
      • 9.4.12.3. Market Size and Forecast, By Technique
      • 9.4.12.4. Market Size and Forecast, By Application
      • 9.4.12.5. Market Size and Forecast, By End User
    • 9.4.13. Rest of Asia-Pacific Vacuum-assisted Biopsy Devices Market
      • 9.4.13.1. Market Size and Forecast, By Product
      • 9.4.13.2. Market Size and Forecast, By Type
      • 9.4.13.3. Market Size and Forecast, By Technique
      • 9.4.13.4. Market Size and Forecast, By Application
      • 9.4.13.5. Market Size and Forecast, By End User
  • 9.5. LAMEA
    • 9.5.1. Key Market Trends and Opportunities
    • 9.5.2. Market Size and Forecast, By Product
    • 9.5.3. Market Size and Forecast, By Type
    • 9.5.4. Market Size and Forecast, By Technique
    • 9.5.5. Market Size and Forecast, By Application
    • 9.5.6. Market Size and Forecast, By End User
    • 9.5.7. Market Size and Forecast, By Country
    • 9.5.8. Brazil Vacuum-assisted Biopsy Devices Market
      • 9.5.8.1. Market Size and Forecast, By Product
      • 9.5.8.2. Market Size and Forecast, By Type
      • 9.5.8.3. Market Size and Forecast, By Technique
      • 9.5.8.4. Market Size and Forecast, By Application
      • 9.5.8.5. Market Size and Forecast, By End User
    • 9.5.9. Saudi Arabia Vacuum-assisted Biopsy Devices Market
      • 9.5.9.1. Market Size and Forecast, By Product
      • 9.5.9.2. Market Size and Forecast, By Type
      • 9.5.9.3. Market Size and Forecast, By Technique
      • 9.5.9.4. Market Size and Forecast, By Application
      • 9.5.9.5. Market Size and Forecast, By End User
    • 9.5.10. South Africa Vacuum-assisted Biopsy Devices Market
      • 9.5.10.1. Market Size and Forecast, By Product
      • 9.5.10.2. Market Size and Forecast, By Type
      • 9.5.10.3. Market Size and Forecast, By Technique
      • 9.5.10.4. Market Size and Forecast, By Application
      • 9.5.10.5. Market Size and Forecast, By End User
    • 9.5.11. Rest of LAMEA Vacuum-assisted Biopsy Devices Market
      • 9.5.11.1. Market Size and Forecast, By Product
      • 9.5.11.2. Market Size and Forecast, By Type
      • 9.5.11.3. Market Size and Forecast, By Technique
      • 9.5.11.4. Market Size and Forecast, By Application
      • 9.5.11.5. Market Size and Forecast, By End User

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top Winning Strategies
  • 10.3. Product Mapping of Top 10 Player
  • 10.4. Competitive Dashboard
  • 10.5. Competitive Heatmap
  • 10.6. Top Player Positioning, 2023

CHAPTER 11: COMPANY PROFILES

  • 11.1. Becton, Dickinson And Company
    • 11.1.1. Company Overview
    • 11.1.2. Key Executives
    • 11.1.3. Company Snapshot
    • 11.1.4. Operating Business Segments
    • 11.1.5. Product Portfolio
    • 11.1.6. Business Performance
    • 11.1.7. Key Strategic Moves and Developments
  • 11.2. Cook Group
    • 11.2.1. Company Overview
    • 11.2.2. Key Executives
    • 11.2.3. Company Snapshot
    • 11.2.4. Operating Business Segments
    • 11.2.5. Product Portfolio
    • 11.2.6. Business Performance
    • 11.2.7. Key Strategic Moves and Developments
  • 11.3. Devicor Medical Products Inc
    • 11.3.1. Company Overview
    • 11.3.2. Key Executives
    • 11.3.3. Company Snapshot
    • 11.3.4. Operating Business Segments
    • 11.3.5. Product Portfolio
    • 11.3.6. Business Performance
    • 11.3.7. Key Strategic Moves and Developments
  • 11.4. Argon Medical Devices, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Key Executives
    • 11.4.3. Company Snapshot
    • 11.4.4. Operating Business Segments
    • 11.4.5. Product Portfolio
    • 11.4.6. Business Performance
    • 11.4.7. Key Strategic Moves and Developments
  • 11.5. B. Braun Melsungen AG
    • 11.5.1. Company Overview
    • 11.5.2. Key Executives
    • 11.5.3. Company Snapshot
    • 11.5.4. Operating Business Segments
    • 11.5.5. Product Portfolio
    • 11.5.6. Business Performance
    • 11.5.7. Key Strategic Moves and Developments
  • 11.6. Cardinal Health
    • 11.6.1. Company Overview
    • 11.6.2. Key Executives
    • 11.6.3. Company Snapshot
    • 11.6.4. Operating Business Segments
    • 11.6.5. Product Portfolio
    • 11.6.6. Business Performance
    • 11.6.7. Key Strategic Moves and Developments
  • 11.7. Olympus Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Key Executives
    • 11.7.3. Company Snapshot
    • 11.7.4. Operating Business Segments
    • 11.7.5. Product Portfolio
    • 11.7.6. Business Performance
    • 11.7.7. Key Strategic Moves and Developments
  • 11.8. Boston Scientific Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Key Executives
    • 11.8.3. Company Snapshot
    • 11.8.4. Operating Business Segments
    • 11.8.5. Product Portfolio
    • 11.8.6. Business Performance
    • 11.8.7. Key Strategic Moves and Developments
  • 11.9. Medtronic Plc
    • 11.9.1. Company Overview
    • 11.9.2. Key Executives
    • 11.9.3. Company Snapshot
    • 11.9.4. Operating Business Segments
    • 11.9.5. Product Portfolio
    • 11.9.6. Business Performance
    • 11.9.7. Key Strategic Moves and Developments
  • 11.10. Inrad Inc
    • 11.10.1. Company Overview
    • 11.10.2. Key Executives
    • 11.10.3. Company Snapshot
    • 11.10.4. Operating Business Segments
    • 11.10.5. Product Portfolio
    • 11.10.6. Business Performance
    • 11.10.7. Key Strategic Moves and Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!